Abnormal liver function, viral hepatitis B, cirrhosis, liver cancer, fatty liver
Conditions
Interventions
Liver function abnormalities group:None
Sponsors
The First Affiliated Hospital of Guangdong Pharmaceutical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18 <= age of the patient <= 80 years old; (2) Patients who have undergone WMT treatment for the first time in our department and have completed at least two courses of WMT treatment; (3) understand the purpose of this study and voluntarily participate in this study; (4) During WMT treatment, no antibiotics, immunosuppressants and other drugs were taken.
Exclusion criteria
Exclusion criteria: (1) Those who have abnormal speech expression and cannot take care of themselves; (2) pregnant or lactating women; (3) Those who have poor compliance and do not cooperate with the clinical treatment plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver Function;Indicators of liver fibrosis;Blood lipid;Hepatitis B is two halves;Quantitative testing for hepatitis B virus DNA;Plasma prothrombin time assay;fibrotouch; | — |
Countries
China
Contacts
Public ContactHe Xingxiang
The First Affiliated Hospital of Guangdong Pharmaceutical University
Outcome results
None listed